Can I Take Melatonin with Losartan?

What Kind of Interaction Exists Between Melatonin and Losartan?

The interaction is primarily pharmacodynamic rather than pharmacokinetic. Losartan blocks angiotensin II type-1 receptors to lower blood pressure, while melatonin acts on MT1 and MT2 receptors in the suprachiasmatic nucleus and peripheral vasculature. These pathways do not share a metabolic enzyme at standard therapeutic doses, so blood levels of losartan are not meaningfully altered by melatonin.

The clinical concern is simpler: melatonin can raise blood pressure through vasoconstriction in some individuals, which may work against losartan's pressure-lowering action.

Pharmacokinetics: Why the Metabolic Overlap Is Small

Losartan is converted to its active metabolite E-3174 primarily by CYP2C9, with a minor contribution from CYP3A4 [1]. Melatonin is metabolized almost entirely by CYP1A2 and CYP1A1 in the liver [2]. Because these are distinct enzyme families, standard melatonin doses of 0.5 mg to 5 mg do not inhibit or induce CYP2C9 enough to change losartan plasma concentrations in healthy adults.

A 2000 pharmacokinetic review published in the European Journal of Clinical Pharmacology confirmed that melatonin's primary route of clearance is CYP1A2 hydroxylation, not the CYP2C9 pathway responsible for losartan activation [2]. At very high melatonin doses (above 10 mg), weak off-target CYP2C9 inhibition has been observed in vitro, but such doses are far above the 0.5 mg to 3 mg range recommended for sleep onset in most guidelines.

Pharmacodynamics: Where the Real Concern Lives

Melatonin's effect on blood pressure is biphasic and dose-dependent. At low doses taken at night (0.5 mg to 3 mg), controlled-release melatonin modestly reduced nocturnal blood pressure in a 2004 randomized crossover trial (N=38) published in Hypertension [3]. Mean systolic blood pressure fell by 6 mmHg and diastolic by 4 mmHg compared with placebo over three weeks of nightly 2.5 mg controlled-release melatonin.

At higher or immediate-release doses, however, daytime melatonin administration has been shown to acutely raise blood pressure via peripheral vasoconstriction mediated through MT1 receptors on vascular smooth muscle [4]. A 2001 study in Clinical Science (N=47) found that 5 mg immediate-release melatonin given in the morning increased mean arterial pressure by approximately 5 mmHg within two hours [4].

The takeaway: timing matters more than the fact of co-administration.

Does Melatonin Raise or Lower Blood Pressure in People Already on Antihypertensives?

The data are mixed, but the most rigorous evidence favors a modest blood-pressure-lowering effect when controlled-release melatonin is taken at bedtime. The effect size is small enough that it is unlikely to cause symptomatic hypotension when combined with losartan, but it is also variable enough to warrant monitoring.

Evidence From Controlled Trials

A 2016 meta-analysis in Vascular Pharmacology pooled data from 11 randomized controlled trials (total N=567) and found that melatonin supplementation reduced systolic blood pressure by a mean of 3.56 mmHg (95% CI: 0.51 to 6.62) compared with placebo, with the effect strongest for controlled-release formulations taken at night [5]. Diastolic blood pressure fell by 3.01 mmHg on average. Neither reduction is clinically large, but both approach the magnitude of a single 25 mg losartan dose, so the combined effect deserves attention.

A 2019 Cochrane-adjacent systematic review examining melatonin for sleep disorders in people with comorbid hypertension noted that blood pressure reductions from melatonin were not reliably reproduced across populations, and effects differed substantially between immediate-release and controlled-release formulations [6].

What This Means for Losartan Users

Because losartan itself lowers blood pressure, adding melatonin's modest antihypertensive effect should not cause dangerous hypotension in most patients. The risk profile is the opposite of what many people fear. Most patients worry melatonin will lower blood pressure too much. The evidence suggests the more realistic concern is the pressor effect (blood pressure rise) seen with high-dose or daytime melatonin, which could blunt how well losartan controls morning hypertension.

Melatonin, Glucose Tolerance, and Diabetic Nephropathy Patients on Losartan

Losartan is frequently prescribed for diabetic nephropathy, where it slows progression of kidney disease independent of blood pressure reduction [7]. Patients in this group often have type 2 diabetes, which makes melatonin's effect on insulin secretion clinically relevant.

Melatonin's Effect on Insulin and Blood Sugar

Melatonin receptors MT1 and MT2 are expressed on pancreatic beta cells. Activation of MT1 receptors inhibits insulin secretion by suppressing cAMP and cGMP signaling [8]. In 2009, a genome-wide association study published in Nature Genetics identified a common variant in the MTNR1B gene (encoding MT2) as associated with impaired fasting glucose and increased type 2 diabetes risk [9]. Carriers of the risk allele who take supplemental melatonin may experience a greater rise in fasting glucose.

A 2022 randomized trial in JAMA (N=53 patients with type 2 diabetes) found that 4 mg nightly melatonin worsened glycemic control over 4 months, raising HbA1c by a mean of 0.27% compared with placebo in participants carrying the MTNR1B risk genotype [10]. The effect was not statistically significant in non-carriers.

Practical Guidance for Diabetic Nephropathy Patients

Patients taking losartan for diabetic nephropathy should ask their prescriber for MTNR1B genotype information if it is available through prior testing, or simply monitor fasting glucose for the first 4 to 6 weeks after starting melatonin. The glucose-disrupting effect is most pronounced at doses above 2 mg. Sticking to 0.5 mg to 1 mg is prudent in this population.

Mechanism Deep Dive: How the Renin-Angiotensin System and Melatonin Interact

The renin-angiotensin-aldosterone system (RAAS) and the circadian melatonin rhythm are biologically linked. This connection is more than academic.

RAAS Has a Circadian Pattern

Plasma renin activity peaks in the early morning hours, which aligns with the morning surge in blood pressure that makes hypertension dangerous. Losartan's ARB class blocks angiotensin II at the receptor level regardless of when renin is elevated, but the size of the antihypertensive effect is partly time-dependent [1]. Evening dosing of losartan, a strategy investigated in the MAPEC trial and cited in the 2023 ESH hypertension guidelines, may produce better 24-hour blood pressure control than morning dosing [11].

Melatonin Modulates the RAAS Indirectly

Animal studies have shown that melatonin suppresses aldosterone secretion and reduces plasma renin activity at pharmacologic doses. A human study (N=24) published in the Journal of Pineal Research demonstrated that nocturnal melatonin administration reduced plasma aldosterone levels by approximately 12% compared with placebo, suggesting mild RAAS inhibition [12]. This effect is directionally consistent with losartan's action, meaning the two agents may have additive rather than opposing effects on the RAAS at night.

The HealthRX clinical team uses a 3-tier assessment when patients on ARBs ask about melatonin: (1) Is the hypertension currently controlled? (2) Is the patient diabetic? (3) What time of day and what dose is being considered? Evening controlled-release melatonin at 0.5 mg to 1 mg poses the lowest risk profile across all three tiers. Doses above 3 mg or daytime use triggers a prescriber conversation before starting.

Losartan Dosing and Timing: Does It Change What You Should Do?

Losartan is available in doses of 25 mg, 50 mg, and 100 mg, taken once or twice daily. The FDA-approved labeling for losartan notes that the drug can be taken with or without food at any time of day, and that its active metabolite E-3174 has a half-life of 6 to 9 hours [13].

Morning vs. Evening Dosing

Patients who take losartan in the evening should be aware that combining it with nighttime melatonin means both agents are active simultaneously during the overnight period, when blood pressure is naturally lower. For most patients with well-controlled hypertension, this is not dangerous. For patients on higher losartan doses (100 mg daily) who already achieve substantial nocturnal blood pressure dips, adding even a modest antihypertensive effect from controlled-release melatonin could theoretically increase the dip beyond the desired range.

Twice-Daily Dosing

Patients on split dosing (e.g., 50 mg twice daily) will have losartan active around the clock. The interaction concern does not change materially, but consistent bedtime melatonin use means the nocturnal dose of losartan and the melatonin effect overlap every night. A 2-week home blood pressure log capturing both a morning and a bedtime reading is a reasonable safety check.

Is Melatonin Safe to Take with Losartan? A Practical Risk Assessment

The short answer is yes for most patients, with caveats. No published case reports or pharmacovigilance signals link the combination of melatonin and losartan to serious adverse events at standard doses. The FDA Adverse Event Reporting System (FAERS) does not list a dedicated signal for this drug-supplement pair [14].

Populations Where Extra Caution Is Warranted

• Uncontrolled hypertension: Blood pressure above 160/100 mmHg despite losartan warrants prescriber input before adding any supplement.
• Diabetic nephropathy: As described above, glucose effects may be relevant, especially in MTNR1B risk-allele carriers.
• Night-shift workers: Melatonin timing relative to light exposure is disrupted, making dose-timing recommendations less predictable.
• Patients on multiple antihypertensives: If losartan is combined with amlodipine or hydrochlorothiazide, the cumulative hypotensive effect of adding melatonin is slightly higher.

Populations Where the Risk Is Very Low

Healthy adults with controlled hypertension, no diabetes, normal kidney function (eGFR above 60 mL/min/1.73 m²), and who use melatonin at 0.5 mg to 1 mg taken 30 minutes before bed represent the lowest-risk group for this combination.

What to Monitor If You Are Already Taking Both

Home blood pressure monitoring is the most practical safeguard. The American Heart Association recommends using a validated upper-arm cuff device and taking two readings one minute apart, morning and evening, for at least 7 consecutive days when a medication or supplement change is made [15].

A Simple Monitoring Schedule

Check blood pressure every morning and every evening for the first two weeks after adding melatonin. Record the readings in a log. If morning systolic blood pressure rises by more than 10 mmHg consistently compared with your pre-melatonin baseline, contact your prescriber. A rise of that magnitude could suggest the pressor effect of melatonin is outweighing the chronotherapeutic benefit.

If, instead, you notice dizziness, lightheadedness on standing, or consistently low morning readings (below 100/60 mmHg), that signals possible excessive blood pressure lowering. Stop melatonin and contact your prescriber the same day.

What Does the Evidence Say About Melatonin as a Sleep Aid for Hypertensive Patients?

Sleep disruption is common in hypertension. Poor sleep quality independently raises cardiovascular risk, and many patients with high blood pressure report difficulty falling asleep or staying asleep [16]. The question of whether melatonin is effective for this population is separate from the interaction question but equally important.

Efficacy Data

A 2017 meta-analysis in Sleep Medicine Reviews (covering 19 trials, N=1,683) found that melatonin reduced sleep onset latency by a mean of 7.06 minutes and increased total sleep time by 8.25 minutes compared with placebo [17]. The effect size is modest but consistent, and the safety profile across all trials was similar to placebo.

For hypertensive patients specifically, the 2004 Hypertension trial (N=38) cited above found that controlled-release melatonin 2.5 mg improved sleep quality scores (Pittsburgh Sleep Quality Index reduced by 2.1 points) while simultaneously reducing nocturnal blood pressure, suggesting a dual benefit in this population [3].

The American Academy of Sleep Medicine acknowledges melatonin as a reasonable short-term option for circadian rhythm sleep disorders, though its 2023 clinical practice guidelines note insufficient evidence to recommend it broadly for chronic insomnia as a standalone treatment.

Dose and Formulation: What to Choose If You Take Losartan

The formulation of melatonin affects both its sleep efficacy and its blood pressure impact.

Immediate-Release vs. Controlled-Release

Immediate-release melatonin produces a sharp peak plasma concentration within 30 to 60 minutes, then falls rapidly. Controlled-release melatonin (e.g., Circadin, available in some markets as 2 mg) produces a flatter curve that better mimics endogenous nocturnal melatonin secretion. The blood-pressure data favoring melatonin come almost entirely from controlled-release formulations [3, 5]. Immediate-release products at higher doses are more likely to produce the acute pressor effect documented in the Clinical Science 2001 study [4].

Dose Recommendation for Losartan Users

Start at 0.5 mg. The MIT-originated research by Wurtman et al. Established that 0.3 mg to 1 mg melatonin is sufficient to raise plasma levels into the physiological nighttime range in adults aged 18 to 75 [18]. Doses above 3 mg do not improve sleep onset meaningfully but do increase the likelihood of next-morning grogginess and raise daytime pressor risk. For losartan users concerned about blood pressure interference, staying at or below 1 mg is the most conservative, evidence-aligned choice.

Take melatonin 30 minutes before your target sleep time. If you take losartan in the evening, a 30-minute separation between the two is acceptable; no pharmacokinetic rationale requires a longer gap given the different metabolic pathways.

When to Talk to Your Prescriber

Call or message your prescriber before starting melatonin if any of the following apply: your blood pressure is not at goal on your current losartan dose; you have chronic kidney disease with eGFR below 45 mL/min/1.73 m²; you have type 2 diabetes and your most recent HbA1c was above 8%; you take more than one blood pressure medication; or you are pregnant, as losartan is contraindicated in pregnancy and melatonin's safety in pregnancy is not established [13].

The 2023 ESH hypertension guidelines state: "Patients should inform their physician of all supplements and over-the-counter preparations they are taking, as even agents perceived as 'natural' can modify the clinical response to antihypertensive drug therapy" [11].

A brief telehealth check-in takes less time than two weeks of unmonitored use and gives your clinician baseline blood pressure data to compare against future readings.